Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Academia / Non-Profit
Sort By
Newest First
1 / 1
1 / 1
Synthetic Biology
Leaps and Bounds for Synthetic Biology Startups
Macquarie University
PAO-11-24-RTM-13
Nov 15, 2024
Research
Translating Academic Pursuits into Real-World Applications
Macquarie University
PAO-11-24-RTM-12
Nov 15, 2024
Synthetic Biology
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Queensland University of Technology (QUT)
PAO-11-24-RTM-06
Nov 15, 2024
Partnerships
University-Industry Partnerships Tackling Genetic Disease Therapies and Diagnostic Innovation
Avicena Systems
PAO-10-24-RTM-14
Nov 06, 2024
Biosensors
The Partnerships Powering Next-Gen Oncology Care
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-10
Nov 06, 2024
Melanoma
Understanding the Challenges in Tackling Melanoma and Other Forms of Cancer
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-07
Nov 05, 2024
Oncology
Up Close and Personal with Scientists on the Cutting Edge of Melanoma Research
Olivia Newton-John Cancer Research Institute
PAO-10-24-RTM-06
Nov 05, 2024
ADC
World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda
World ADC
PR-10-24-NI-37
Oct 10, 2024
Cord Blood Bank Alliance
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
Be The Match BioTherapies
PR-M07-23-01
Jul 13, 2023
Allogeneic Cell Therapy Logistics
Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement
Joy Aho, Ph.D.
Be The Match BioTherapies
PAO-06-23-CL-06
Jun 27, 2023
Cell Therapy
Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making
Chris McClain
Be The Match BioTherapies
PAO-11-022-CL-01
Nov 01, 2022
Cord Blood
Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical Use
Be The Match BioTherapies
PR-M08-22-02
Aug 13, 2022
Strategic Partnership
Chimeric Partners With Be The Match BioTherapies® To Advance CHM 1101 (CLTX CAR T)
Chimeric Therapeutics
PR-M03-22-07
Mar 17, 2022
Cell Therapy
Expanding Access to Cell Therapies with a Patient-Centric Focus
Amy L. Ronneberg
Be The Match BioTherapies
PAO-02-022-CL-12
Mar 12, 2022
Cell Therapy
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis
Ashish Patel, Ph.D.
The National Institute for Health Research (NIHR) Guy’s and St Thomas’ Biomedical Research Centre (BRC)
PAO-09-21-CL-13
Sep 29, 2021
Cell Therapy
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Chris McClain
Be The Match BioTherapies
PAO-09-21-CL-04
Sep 09, 2021
